Management of Endophytic Squamoproliferative Lesion with Involution

Diagnostic Evaluation

A complete clinical examination of the lesion is recommended, noting any features suspicious for malignancy, according to the British Journal of Dermatology 3
Biopsy of the suspicious area for histopathological confirmation is essential before definitive treatment, as stated by the British Journal of Dermatology and the Journal of the American Academy of Dermatology 1, 4
The pathologist should be provided with key clinical information, including patient demographics, anatomic location, lesion size, and relevant risk factors, as recommended by the Journal of the American Academy of Dermatology 4
Histopathological assessment should evaluate the degree of cellular differentiation, presence of aggressive histologic subtypes, depth of invasion, and presence of perineural or lymphovascular invasion, according to the Journal of the American Academy of Dermatology 4

Wide local excision is the treatment of choice for squamoproliferative lesions, as recommended by the British Journal of Dermatology and the Journal of the American Academy of Dermatology 1, 2, 4
Pre-operative imaging with MRI or CT is recommended for lesions ≥5 cm in diameter or those in anatomically complex locations to assess tumor extent, according to the British Journal of Dermatology 1, 5
The surgical approach should be discussed with the patient, balancing the need for complete removal with functional and cosmetic outcomes, as stated by the British Journal of Dermatology 2, 6

All cases should be discussed in a multidisciplinary meeting with dermatologists, plastic surgeons, histopathologists, and oncologists, as recommended by the British Journal of Dermatology 1, 6
Regional lymph node assessment should be performed if clinically suspicious, according to the British Journal of Dermatology 1, 2
If lymphadenopathy is present, ultrasound-guided fine-needle aspiration or surgical biopsy should be performed, as stated by the British Journal of Dermatology 2
Positive lymph node biopsy should prompt consideration of regional lymph node dissection, according to the British Journal of Dermatology 2

Regular clinical surveillance is essential following treatment, as recommended by the British Journal of Dermatology 3, 6
For patients with completely excised lesions without high-risk features, follow-up examinations every 3-6 months for the first year, then annually, are recommended by the British Journal of Dermatology 3, 6
Any persistent ulceration, new growth, or suspicious changes should prompt immediate re-evaluation, according to the British Journal of Dermatology 5, 7

Delay in biopsy of suspicious lesions can lead to missed diagnosis of malignancy, as stated by the British Journal of Dermatology 3, 5
Inadequate surgical margins increase the risk of recurrence, according to the British Journal of Dermatology and the Journal of the American Academy of Dermatology 2, 4
Failure to assess regional lymph nodes in cases with high-risk features can lead to poor outcomes, as recommended by the British Journal of Dermatology 1, 2
Overlooking the possibility of malignant transformation in longstanding lesions can lead to delayed diagnosis, according to the British Journal of Dermatology and the Journal of the American Academy of Dermatology 4, 7